The Human Pharmacokinetics of Elismetrep (T34) Summary A TRPM8 Migraine-Associated Channel Blocker (MACB), are Well-Suited for a Migraine Therapeutic. Content Elismetrep-Human-PK-Poster-T34-updated.pdf ← Back to Resource Library
